Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03143608 · ClinicalTrials.gov registry record

GERD Treatment With Transoral Incisionless Fundoplication (TIF) Following Hiatal Hernia Surgery

A clinical trial of Gastro Esophageal Reflux, sponsored by Peter G Mavrelis.

Completed
Registry status
99
Enrollment target
2
Study locations

NCT03143608 is a study of Gastro Esophageal Reflux that has completed, run by Peter G Mavrelis. The registered enrollment target is 99 participants, below the 12,932-participant average among 7 other Gastro Esophageal Reflux trials with a reported enrollment target (99% lower). The trial reports 2 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03143608, a study of Gastro Esophageal Reflux, has completed, sponsored by Peter G Mavrelis.

COMPLETED
Registry status
99 participants
Enrollment target
2
Study locations

Study Summary

The investigators prospectively studied ninety nine GERD patients following laparoscopic hiatal surgery combined with transoral incisionless fundoplication at two community hospitals. General surgeons and gastroenterologists participated in the study. GERD questions were recorded before and at six and twelve months.

Conditions Studied

Interventions

  • DEVICE Esophyx

Study Locations (2)

Indiana

  • Methodist Hospital - Merrillville

Wisconsin

  • Affinity Health System - Appleton

Trial Details

FieldValue
Enrollment Target 99 participants
Start Date 2014-05-01
Est. Completion 2016-12-31

Sponsor

Peter G Mavrelis

1 total trials

What the Registry Record Tells You About NCT03143608

The ClinicalTrials.gov registry entry for NCT03143608 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 99 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 12,932-participant average among 7 other Gastro Esophageal Reflux trials with a reported enrollment target (99% lower). The listed sponsor is Peter G Mavrelis, which has 1 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Gastro Esophageal Reflux appearing as the primary indexed condition, and to 1 intervention - of which Esophyx is the first listed.

NCT03143608 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Indiana, Wisconsin.

Frequently Asked Questions

What is clinical trial NCT03143608 about?

NCT03143608 is a clinical study titled "GERD Treatment With Transoral Incisionless Fundoplication (TIF) Following Hiatal Hernia Surgery". The investigators prospectively studied ninety nine GERD patients following laparoscopic hiatal surgery combined with transoral incisionless fundoplication at two community hospitals. General surgeons and gastroenterologists participated in the study. GERD questions were recorded before and at six a...

What is the current status of trial NCT03143608?

This trial is currently completed. The enrollment target is 99 participants. The study started on 2014-05-01. Estimated completion is 2016-12-31.

What conditions does trial NCT03143608 study?

This clinical trial studies the following conditions: Gastro Esophageal Reflux.

What interventions are being tested in trial NCT03143608?

The interventions under investigation include: Esophyx (DEVICE).

Who is sponsoring clinical trial NCT03143608?

This trial is sponsored by Peter G Mavrelis, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03143608 being conducted?

This trial has 2 study locations across Indiana, Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Gastro Esophageal Reflux

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.